Single Nucleotide Variant Detection Using Next Generation Sequencing

作者: David H. Spencer , Bin Zhang , John Pfeifer

DOI: 10.1016/B978-0-12-404748-8.00008-3

关键词:

摘要: Single nucleotide variants (SNVs) occur when a single (e.g., A, T, C, or G) is altered in the DNA sequence. SNVs are by far most common type of sequence change, and there number endogenous exogenous sources damage that lead to base pair substitution mutations create SNVs. The biologic impact coding regions depends on their (synonymous versus missense), noncoding RNA processing gene regulation. Nonetheless, selection pressure reduces overall frequency substitutions associated regulatory sequences, with result SNV rate much less than DNA. utility clinical next generation sequencing (NGS) assay designed detect design features including an amplification-based hybrid capture-based targeted approach, library complexity, depth sequencing, tumor cellularity (in cancer specimens), specimen fixation, platform. From bioinformatic perspective, many popular NGS analysis programs for detection constitutional genome where either 50% (heterozygous) 100% (homozygous) reads; these prior probabilities often built-in algorithms, consequently variant allele frequencies (VAFs) falling too outside expected range homozygous heterozygous ignored as false positives. Thus, sensitive specific approaches acquired require significant revision software packages testing new algorithms altogether. Some tools optimized very data, but high coverage acceptable performance rely spike-in control samples order calibrate run-dependent error models, must be accounted design. There online can used predict evaluate whether has documented disease association. Guidelines reporting detected have been developed; consensus guidelines somatic under development.

参考文章(107)
JM Gonzalez-Redondo, TA Stoming, A Kutlar, F Kutlar, KD Lanclos, EF Howard, YJ Fei, M Aksoy, C Altay, A Gurgey, A C----T substitution at nt--101 in a conserved DNA sequence of the promotor region of the beta-globin gene is associated with “silent” beta-thalassemia Blood. ,vol. 73, pp. 1705- 1711 ,(1989) , 10.1182/BLOOD.V73.6.1705.1705
Hope E. Karnes, Eric J. Duncavage, Cory T. Bernadt, Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung. Cancer Cytopathology. ,vol. 122, pp. 104- 113 ,(2014) , 10.1002/CNCY.21361
Lynne E Maquat, The power of point mutations Nature Genetics. ,vol. 27, pp. 5- 6 ,(2001) , 10.1038/83759
R. Barnard, V. Futo, N. Pecheniuk, M. Slattery, T. Walsh, PCR bias toward the wild-type k-ras and p53 sequences: implications for PCR detection of mutations and cancer diagnosis. BioTechniques. ,vol. 25, pp. 684- 691 ,(1998) , 10.2144/98254DT08
David H. Ledbetter, Howard P. Levy, Elaine Lyon, Donna Maglott, Howard L. McLeod, Nazneen Rahman, Gurvaneet Randhawa, Catherine Wicklund, Teri A. Manolio, Rex L. Chisholm, Marc S. Williams, Erin M. Ramos, Corina Din-Lovinescu, Jonathan S. Berg, Lisa D. Brooks, Audrey Duncanson, Michael Dunn, Peter Good, Tim J.P. Hubbard, Gail P. Jarvik, Christopher O'Donnell, Stephen T. Sherry, Naomi Aronson, Leslie G. Biesecker, Bruce Blumberg, Ned Calonge, Helen M. Colhoun, Robert S. Epstein, Paul Flicek, Erynn S. Gordon, Eric D. Green, Robert C. Green, Matthew Hurles, Kensaku Kawamoto, William Knaus, Characterizing genetic variants for clinical action. American Journal of Medical Genetics Part C-seminars in Medical Genetics. ,vol. 166, pp. 93- 104 ,(2014) , 10.1002/AJMG.C.31386
W D Henner, L O Rodriguez, S M Hecht, W A Haseltine, gamma Ray induced deoxyribonucleic acid strand breaks. 3' Glycolate termini. Journal of Biological Chemistry. ,vol. 258, pp. 711- 713 ,(1983) , 10.1016/S0021-9258(18)33104-1
Gabor Marth, Erik Garrison, Haplotype-based variant detection from short-read sequencing arXiv: Genomics. ,(2012)